3[1]Hu W, Liu J, Niu S, et al. Prevalence of CMV in arterial walls and leukocytes in patients with atherosclerosis [J].Chin Med J, 2001,114(11):1208-1210.
4[2]Adam E, Melnick JL, Probtsfield JL, et al. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis[J]. Lancet, 1987,2(8554):291-293.
5[3]Prichard MN, Penfold ME, Duke GM, et al. A review of genetic differences between limited and extensively passaged human cytomegalovirus strains [J]. Rev Med Virol, 2001,11(3):191-200.
6[4]Castillo JP, Kowalik TF. HCMV infection: modulating the cell cycle and cell death[J]. Int Rev Immunol, 2004,23(1-2):113-139.
7[5]Lunardi C, Bason C, Corrocher R, et al. Induction of endothelial cell damage by hCMV molecular mimicry [J].Trends Immunol, 2005,26(1):19-24.
8[6]Fong IW. Infections and their role in atherosclerotic vascular disease[J]. J Am Dent Assoc, 2002,133 (Suppl):7S-13S.
9[7]Ibrahim AI, Obeid MT, Jouma MJ, et al. Detection of herpes simplex virus, cytomegalovirus and Epstein-Barr virus DNA in atherosclerotic plaques and in unaffected bypass grafts[J]. J Clin Virol, 2005,32(1):29-32.
10[8]Kloppenburg G, de Graaf R, Herngreen S, et al.Cytomegalovirus aggravates intimal hyperplasia in rats by stimulating smooth muscle cell proliferation[J]. Microbes Infect, 2005,7(2):164-170.
